Alnylam Pharmaceuticals
ALNY
#644
Rank
ยฃ28.99 B
Marketcap
ยฃ217.17
Share price
-0.29%
Change (1 day)
6.82%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: ยฃ28.99 Billion

As of May 2026 Alnylam Pharmaceuticals has a market cap of ยฃ28.99 Billion. This makes Alnylam Pharmaceuticals the world's 644th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ28.99 B-26.22%
2025ยฃ39.29 B60.67%
2024ยฃ24.45 B29.72%
2023ยฃ18.85 B-21.98%
2022ยฃ24.16 B60.84%
2021ยฃ15.02 B35.63%
2020ยฃ11.07 B12.43%
2019ยฃ9.85 B69.55%
2018ยฃ5.81 B-37.66%
2017ยฃ9.32 B258.04%
2016ยฃ2.60 B-51.83%
2015ยฃ5.40 B12.38%
2014ยฃ4.80 B93.58%
2013ยฃ2.48 B319.24%
2012ยฃ0.59 B164.54%
2011ยฃ0.22 B-17.16%
2010ยฃ0.27 B-40.63%
2009ยฃ0.45 B-34.81%
2008ยฃ0.69 B17.08%
2007ยฃ0.59 B47.44%
2006ยฃ0.40 B170.95%
2005ยฃ0.14 B99.11%
2004ยฃ75.03 M

End of Day market cap according to different sources

On May 10th, 2026 the market cap of Alnylam Pharmaceuticals was reported to be:

ยฃ28.99 Billion
by Nasdaq info icon info icon
ยฃ28.99 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
ยฃ205.09 B 607.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
ยฃ76.37 B 163.41%๐Ÿ‡ซ๐Ÿ‡ท France
Regeneron Pharmaceuticals
REGN
ยฃ55.16 B 90.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
ยฃ1.55 B-94.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
ยฃ0.41 B-98.57%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
ยฃ0.63 B-97.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ30.62 B 5.62%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Arrowhead Pharmaceuticals
ARWR
ยฃ7.53 B-74.01%๐Ÿ‡บ๐Ÿ‡ธ USA